Inter Pharma PCL (BKK:IP)

Market Cap	2.07B
Revenue (ttm)	1.91B
Net Income (ttm)	37.28M
Shares Out	605.34M
EPS (ttm)	0.06
PE Ratio	55.54
Forward PE	n/a
Dividend	0.02 (0.66%)
Ex-Dividend Date	n/a

Volume	1,710,398
Average Volume	3,134,575
Open	3.460
Previous Close	3.420
Day's Range	3.440 - 3.580
52-Week Range	2.020 - 6.950
Beta	0.93
RSI	55.74
Earnings Date	May 9, 2025

About Inter Pharma PCL

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IP

Financial Performance

In 2024, Inter Pharma PCL's revenue was 1.91 billion, an increase of 6.29% compared to the previous year's 1.80 billion. Earnings were 37.28 million, a decrease of -26.60%.